Detecting Oligomeric Beta-Amyloid for the Diagnosis of Alzheimer's Disease

abstract: Alzheimer's disease (AD) is the leading neurodegenerative disease, affecting roughly 8% of people 65 years of age or older. There exists an imperative need to develop a non-invasive test for the earlier detection of AD. The use of biomarkers is a promising option that examines the tox...

Full description

Bibliographic Details
Other Authors: Brownlee, Taylor (Author)
Format: Dissertation
Language:English
Published: 2013
Subjects:
Online Access:http://hdl.handle.net/2286/R.I.17777